• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法国围产期队列中感染HIV-1的新生儿的齐多夫定基因型耐药性

Zidovudine genotypic resistance in HIV-1-infected newborns in the French perinatal cohort.

作者信息

Masquelier B, Chaix M L, Burgard M, Lechenadec J, Doussin A, Simon F, Cottalorda J, Izopet J, Tamalet C, Douard D, Fleury H, Mayaux M J, Blanche S, Rouzioux C

机构信息

Laboratoires de Virologie, Centres Hospitaliers Universitaires de Bordeaux, Hôpital Pellegrin, Place Amelie Raba Léon, 33076 Bordeaux CEDEX France.

出版信息

J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):99-104. doi: 10.1097/00126334-200106010-00001.

DOI:10.1097/00126334-200106010-00001
PMID:11404530
Abstract

A retrospective study was set up to investigate the frequency of zidovudine (ZDV)-resistant HIV-1 in infected newborns after ZDV prophylaxis in the French Perinatal Cohort study. Nucleotide sequence analysis was carried out from 34 infants' isolates and 18 maternal plasma samples. Mutations related to ZDV resistance were found in the HIV-1 reverse transcriptase in 7 of 34 children (20%). Evidence of mother-child transmission of ZDV-resistant HIV-1 was found in 4 cases. Phylogenetic analysis showed that 14 of 34 HIV-1 isolates from the infants belonged to non-B subtypes. The presence of ZDV resistance-encoding mutations in the newborn isolates was associated with a longer total duration of exposure to ZDV. In a context of a wide HIV-1 variability, ZDV resistance can be one of the factors contributing to mother-child transmission.

摘要

在法国围产期队列研究中,开展了一项回顾性研究,以调查接受齐多夫定(ZDV)预防治疗的感染新生儿中对ZDV耐药的HIV-1的出现频率。对34例婴儿的病毒分离株和18份母亲血浆样本进行了核苷酸序列分析。在34名儿童中的7名(20%)的HIV-1逆转录酶中发现了与ZDV耐药相关的突变。在4例病例中发现了母婴传播ZDV耐药HIV-1的证据。系统发育分析表明,34例婴儿的HIV-1分离株中有14株属于非B亚型。新生儿分离株中存在ZDV耐药编码突变与ZDV暴露总时长较长有关。在HIV-1高度变异的情况下,ZDV耐药可能是导致母婴传播的因素之一。

相似文献

1
Zidovudine genotypic resistance in HIV-1-infected newborns in the French perinatal cohort.法国围产期队列中感染HIV-1的新生儿的齐多夫定基因型耐药性
J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):99-104. doi: 10.1097/00126334-200106010-00001.
2
HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.妇女与婴儿传播研究中HIV-1基因型齐多夫定耐药性与母婴传播风险。妇女与婴儿传播研究小组。
AIDS. 2000 Feb 18;14(3):263-71. doi: 10.1097/00002030-200002180-00008.
3
Selective vertical transmission of HIV-1 antiretroviral resistance mutations.HIV-1抗逆转录病毒耐药性突变的选择性垂直传播。
AIDS. 1998 Dec 3;12(17):2281-8. doi: 10.1097/00002030-199817000-00009.
4
Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995--1999.1995 - 1999年纽约队列中感染人类免疫缺陷病毒1型的孕妇T215Y突变的流行情况。
Clin Infect Dis. 2001 Jul 1;33(1):e3-7. doi: 10.1086/320877. Epub 2001 Jun 6.
5
Effect of perinatal short-course zidovudine on the clinical and virological manifestations of HIV-1 subtype E infection in infants.围产期短期齐多夫定对婴儿HIV-1 E亚型感染临床及病毒学表现的影响。
J Clin Virol. 2002 Jul;25(1):47-56. doi: 10.1016/s1386-6532(01)00258-x.
6
Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life.在孕期或出生后接触齐多夫定且在出生后前三个月接受去羟肌苷或齐多夫定治疗的婴儿中,去羟肌苷的药代动力学及耐药性突变情况。
Pediatr Infect Dis J. 2005 Jun;24(6):503-9. doi: 10.1097/01.inf.0000164787.63237.0b.
7
Occurrence of HIV-1 reverse transcriptase gene mutation at codon 215 in HIV-infected infants.
J Clin Virol. 2001 Aug;22(1):143-8. doi: 10.1016/s1386-6532(01)00178-0.
8
Effectiveness of short-term and long-term zidovudine prophylaxis on detection of HIV-1 subtype E in human placenta and vertical transmission.短期和长期齐多夫定预防对人胎盘HIV-1 E亚型检测及垂直传播的有效性
J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):545-50. doi: 10.1097/01.qai.0000185572.90849.4d.
9
Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains.
AIDS. 2001 Nov 23;15(17):2293-301. doi: 10.1097/00002030-200111230-00011.
10
HIV-1 reverse transcriptase codon 215 mutation in plasma RNA: immunologic and virologic responses to zidovudine. The AIDS Clinical Trials Group Study 175 Virology Team.血浆RNA中HIV-1逆转录酶密码子215突变:对齐多夫定的免疫和病毒学反应。艾滋病临床试验组研究175病毒学团队。
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Mar 1;17(3):203-8. doi: 10.1097/00042560-199803010-00003.

引用本文的文献

1
Global, regional, and national prevalence of HIV-1 drug resistance in treatment-naive and treatment-experienced children and adolescents: a systematic review and meta-analysis.初治和经治儿童及青少年中HIV-1耐药性的全球、区域和国家流行率:一项系统评价和荟萃分析。
EClinicalMedicine. 2024 Oct 4;77:102859. doi: 10.1016/j.eclinm.2024.102859. eCollection 2024 Nov.
2
Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project.治疗前耐药对HIV感染儿童开始抗逆转录病毒治疗的病毒学反应的影响及流行情况——一项欧洲协调-欧洲艾滋病临床与流行病学研究协作网-欧洲儿科感染性疾病研究协作组联合项目
BMC Infect Dis. 2016 Nov 8;16(1):654. doi: 10.1186/s12879-016-1968-2.
3
Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome.围产期获得耐药性 HIV-1 感染:机制和长期结局。
Retrovirology. 2009 Sep 19;6:85. doi: 10.1186/1742-4690-6-85.
4
Effectiveness of nevirapine and zidovudine in a pilot program for the prevention of mother-to-child transmission of HIV-1 in Uganda.奈韦拉平和齐多夫定在乌干达预防HIV-1母婴传播试点项目中的有效性。
Afr Health Sci. 2004 Dec;4(3):146-54.
5
A pilot study to evaluate the safety and feasibility of the administration of AZT/3TC fixed dose combination to HIV infected pregnant women and their infants in Rio de Janeiro, Brazil.一项评估齐多夫定/拉米夫定固定剂量组合用于巴西里约热内卢感染HIV的孕妇及其婴儿的安全性和可行性的试点研究。
Sex Transm Infect. 2003 Dec;79(6):448-52. doi: 10.1136/sti.79.6.448.